Francis M Cuss - Net Worth and Insider Trading

Francis M Cuss Net Worth

The estimated net worth of Francis M Cuss is at least $14 Million dollars as of 2024-03-28. Francis M Cuss is the EVP & CSO of Bristol-Myers Squibb Co and owns about 266,033 shares of Bristol-Myers Squibb Co (BMY) stock worth over $14 Million. Francis M Cuss is also the Director of Rubius Therapeutics Inc and owns about 10,000 shares of Rubius Therapeutics Inc (RUBY) stock worth over $570. Details can be seen in Francis M Cuss's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Francis M Cuss has not made any transactions after 2018-07-20 and currently still holds the listed stock(s).

Transaction Summary of Francis M Cuss

To

Francis M Cuss Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Francis M Cuss owns 2 companies in total, including Rubius Therapeutics Inc () , and Bristol-Myers Squibb Co () .

Click here to see the complete history of Francis M Cuss’s form 4 insider trades.

Insider Ownership Summary of Francis M Cuss

Ticker Comapny Transaction Date Type of Owner
Rubius Therapeutics Inc 2018-07-20 director
Bristol-Myers Squibb Co 2015-03-16 EVP & CSO

Francis M Cuss Latest Holdings Summary

Francis M Cuss currently owns a total of 2 stocks. Among these stocks, Francis M Cuss owns 266,033 shares of Bristol-Myers Squibb Co (BMY) as of March 16, 2015, with a value of $14 Million and a weighting of 100%. Francis M Cuss also owns 10,000 shares of Rubius Therapeutics Inc (RUBY) as of July 20, 2018, with a value of $570 and a weighting of 0%.

Latest Holdings of Francis M Cuss

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BMY Bristol-Myers Squibb Co 2015-03-16 266,033 54.17 14,409,677
RUBY Rubius Therapeutics Inc 2018-07-20 10,000 0.06 570

Holding Weightings of Francis M Cuss


Francis M Cuss Form 4 Trading Tracker

According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Bristol-Myers Squibb Co (BMY) over the past 5 years. The most-recent trade in Bristol-Myers Squibb Co is the sale of 114,666 shares on March 16, 2015, which brought Francis M Cuss around $8 Million.

According to the SEC Form 4 filings, Francis M Cuss has made a total of 0 transactions in Rubius Therapeutics Inc (RUBY) over the past 5 years. The most-recent trade in Rubius Therapeutics Inc is the acquisition of 10,000 shares on July 20, 2018, which cost Francis M Cuss around $230,000.

Insider Trading History of Francis M Cuss

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Francis M Cuss Trading Performance

GuruFocus tracks the stock performance after each of Francis M Cuss's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Francis M Cuss is -35.46%. GuruFocus also compares Francis M Cuss's trading performance to market benchmark return within the same time period. The performance of stocks bought by Francis M Cuss within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Francis M Cuss's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Francis M Cuss

Average Relative Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Relative Return(%) -14.58 -35.46 -47.36 -43.18 -51.83 -5.24
Relative Return to S&P 500(%) -16.55 -34.24 -42.68 -49.42 -59.55 -20.78

Francis M Cuss Ownership Network

Ownership Network List of Francis M Cuss

No Data

Ownership Network Relation of Francis M Cuss


Francis M Cuss Owned Company Details

What does Rubius Therapeutics Inc do?

Who are the key executives at Rubius Therapeutics Inc?

Francis M Cuss is the director of Rubius Therapeutics Inc. Other key executives at Rubius Therapeutics Inc include CEO and President Dannielle Appelhans , director & Chief Executive Officer Pablo J Cagnoni , and Chief Scientific Officer Laurence A. Turka .

Rubius Therapeutics Inc () Insider Trades Summary

Over the past 18 months, Francis M Cuss made no insider transaction in Rubius Therapeutics Inc (). Other recent insider transactions involving Rubius Therapeutics Inc () include a net sale of 15,688 shares made by Pablo J Cagnoni , a net sale of 14,263 shares made by Dannielle Appelhans , and a net sale of 2,593 shares made by Laurence A. Turka .

In summary, during the past 3 months, insiders sold 0 shares of Rubius Therapeutics Inc () in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 32,544 shares of Rubius Therapeutics Inc () were sold and 0 shares were bought by its insiders, resulting in a net sale of 32,544 shares.

Rubius Therapeutics Inc ()'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Rubius Therapeutics Inc Insider Transactions

No Available Data

Francis M Cuss Mailing Address

Above is the net worth, insider trading, and ownership report for Francis M Cuss. You might contact Francis M Cuss via mailing address: Bristol-myers Squibb Company, Route 206 & Province Line Road, Princeton Nj 08543.

Discussions on Francis M Cuss

No discussions yet.